In renal cell carcinoma, survival analysis reveals that the ectopic expression of arrestin-1 is associated with the abnormal hypomethylation of its promoter in tumors and is also associated with a 70% decrease in five-year survival [27]. This evidence concerns the gene SAG and renal cell carcinoma.